| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.01e-07 | 18 | 134 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.60e-07 | 37 | 134 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.10e-06 | 28 | 134 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.52e-06 | 70 | 134 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 8.64e-05 | 35 | 134 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.45e-04 | 118 | 134 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.00e-04 | 48 | 134 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.25e-04 | 49 | 134 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP24 TRIO KALRN MCF2 TBC1D13 NPRL2 TBC1D1 ITSN2 DOCK7 MCF2L TBC1D21 | 6.29e-04 | 507 | 134 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP24 TRIO KALRN MCF2 TBC1D13 NPRL2 TBC1D1 ITSN2 DOCK7 MCF2L TBC1D21 | 6.29e-04 | 507 | 134 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | retinoic acid binding | 8.56e-04 | 28 | 134 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | 3-chloroallyl aldehyde dehydrogenase activity | 9.18e-04 | 7 | 134 | 2 | GO:0004028 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | CPAMD8 ARHGAP24 HTR2A TRIO KALRN MCF2 PSME2 ITIH4 TBC1D13 NPRL2 THADA PIK3CA PIK3R1 TBC1D1 ITSN2 DOCK7 MCF2L TBC1D21 NOS2 IL6ST | 1.24e-03 | 1418 | 134 | 20 | GO:0030234 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 CFAP54 DNAH17 TTC12 VPS13A DNAH5 TBC1D21 DNAH11 | 1.29e-08 | 210 | 134 | 12 | GO:0060294 |
| GeneOntologyBiologicalProcess | cilium movement | OFD1 DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 CFAP54 DNAH17 TTC12 VPS13A DNAH5 TBC1D21 DNAH11 | 1.61e-08 | 261 | 134 | 13 | GO:0003341 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 CFAP54 DNAH17 TTC12 VPS13A DNAH5 TBC1D21 DNAH11 | 1.67e-08 | 215 | 134 | 12 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 CFAP54 DNAH17 TTC12 VPS13A DNAH5 TBC1D21 DNAH11 | 1.67e-08 | 215 | 134 | 12 | GO:0001539 |
| GeneOntologyBiologicalProcess | axoneme assembly | 3.87e-08 | 109 | 134 | 9 | GO:0035082 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 1.17e-07 | 8 | 134 | 4 | GO:0070980 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | OFD1 DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 CFAP54 DNAH17 TTC12 VAMP7 VPS13A KIF28P DNAH5 TBC1D21 HTT DNAH11 | 1.36e-07 | 493 | 134 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 2.51e-07 | 41 | 134 | 6 | GO:0070286 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 3.47e-07 | 10 | 134 | 4 | GO:0018879 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 4.52e-07 | 145 | 134 | 9 | GO:0001578 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 8.10e-07 | 12 | 134 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | cilium assembly | OFD1 DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 TBC1D13 CFAP54 TBC1D1 DNAH17 TTC12 DNAH5 TBC1D21 HTT | 1.22e-06 | 444 | 134 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ARHGAP24 OFD1 DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 TBC1D13 CFAP54 PIK3CA PIK3R1 TBC1D1 DNAH17 TTC12 DNAH5 TBC1D21 HTT | 1.67e-06 | 670 | 134 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | ARHGAP24 OFD1 DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 TBC1D13 CFAP54 PIK3CA PIK3R1 TBC1D1 DNAH17 TTC12 DNAH5 TBC1D21 HTT | 2.26e-06 | 685 | 134 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium organization | OFD1 DYNC2H1 DNAAF11 DNAI3 DNAH7 FSIP2 TBC1D13 CFAP54 TBC1D1 DNAH17 TTC12 DNAH5 TBC1D21 HTT | 2.75e-06 | 476 | 134 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 9.36e-06 | 21 | 134 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | microtubule-based process | NEK6 OFD1 DYNC2H1 DNAAF11 DNAI3 LYST DNAH7 FSIP2 CFAP54 DNAH17 TTC12 VAMP7 VPS13A DOCK7 KIF28P DNAH5 TBC1D21 VBP1 HTT DNAH11 | 1.64e-05 | 1058 | 134 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.28e-05 | 26 | 134 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.28e-05 | 26 | 134 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | motile cilium assembly | 2.35e-05 | 88 | 134 | 6 | GO:0044458 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 2.98e-05 | 186 | 134 | 8 | GO:0030317 | |
| GeneOntologyBiologicalProcess | sperm motility | 3.87e-05 | 193 | 134 | 8 | GO:0097722 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 4.06e-05 | 59 | 134 | 5 | GO:0003351 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 4.20e-05 | 253 | 134 | 9 | GO:0099111 | |
| GeneOntologyBiologicalProcess | organelle assembly | CDS1 NEK6 OFD1 DYNC2H1 NTRK3 DNAAF11 DNAI3 DNAH7 FSIP2 TBC1D13 CFAP54 ERAL1 TBC1D1 DNAH17 TTC12 DOCK7 DNAH5 TBC1D21 HTT KNL1 | 4.60e-05 | 1138 | 134 | 20 | GO:0070925 |
| GeneOntologyBiologicalProcess | extracellular transport | 5.16e-05 | 62 | 134 | 5 | GO:0006858 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 7.87e-05 | 109 | 134 | 6 | GO:0090630 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | TMEM126A HTR2A KALRN DYNC2H1 RANBP6 SRP72 DNAAF11 TGFB2 FSIP2 VPS13D GRXCR2 PIK3R1 VAMP7 VPS13A MKLN1 SPIDR HTT KNL1 DNAH11 | 8.19e-05 | 1091 | 134 | 19 | GO:0033365 |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 9.52e-05 | 37 | 134 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 9.52e-05 | 37 | 134 | 4 | GO:0042178 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.06e-04 | 38 | 134 | 4 | GO:0008209 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in determination of left/right asymmetry | 1.15e-04 | 15 | 134 | 3 | GO:0060287 | |
| GeneOntologyBiologicalProcess | inner dynein arm assembly | 1.71e-04 | 17 | 134 | 3 | GO:0036159 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.62e-04 | 52 | 134 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.14e-04 | 5 | 134 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 4.82e-04 | 56 | 134 | 4 | GO:0120316 | |
| GeneOntologyBiologicalProcess | outer dynein arm assembly | 4.91e-04 | 24 | 134 | 3 | GO:0036158 | |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 5.14e-04 | 154 | 134 | 6 | GO:0007368 | |
| GeneOntologyBiologicalProcess | left/right pattern formation | 6.71e-04 | 162 | 134 | 6 | GO:0060972 | |
| GeneOntologyCellularComponent | dynein complex | 1.24e-06 | 54 | 134 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | motile cilium | OFD1 DYNC2H1 DNAAF11 HVCN1 DNAH7 FSIP2 KCNU1 DNAH17 VPS13A DNAH5 TBC1D21 DNAH11 | 3.15e-06 | 355 | 134 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | 9+2 motile cilium | DYNC2H1 HVCN1 DNAH7 FSIP2 KCNU1 DNAH17 VPS13A DNAH5 TBC1D21 DNAH11 | 3.22e-06 | 238 | 134 | 10 | GO:0097729 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.84e-05 | 25 | 134 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | axoneme | 5.79e-05 | 207 | 134 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.99e-05 | 208 | 134 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | microtubule associated complex | 8.17e-05 | 161 | 134 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.21e-04 | 230 | 134 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.23e-04 | 40 | 134 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.10e-04 | 317 | 134 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.32e-04 | 360 | 134 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 6.02e-04 | 6 | 134 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | cilium | OFD1 DYNC2H1 DNAAF11 DNAI3 HVCN1 DNAH7 FSIP2 CFAP54 KCNU1 DNAH17 VPS13A TTLL10 DNAH5 TBC1D21 DNAH11 | 6.50e-04 | 898 | 134 | 15 | GO:0005929 |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 1.43e-03 | 9 | 134 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 1.43e-03 | 9 | 134 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.77e-03 | 10 | 134 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | cell body fiber | 2.16e-03 | 11 | 134 | 2 | GO:0070852 | |
| GeneOntologyCellularComponent | outer dynein arm | 2.58e-03 | 12 | 134 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | sperm flagellum | 2.60e-03 | 214 | 134 | 6 | GO:0036126 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | KALRN ENPP3 USP29 COPS3 ITGA2 ALDH1A2 AATK PIK3CA PIK3R1 VAMP7 PKN2 FLRT1 NOS2 HTT | 2.71e-03 | 934 | 134 | 14 | GO:0048471 |
| HumanPheno | Abnormal sperm motility | 2.52e-06 | 115 | 54 | 9 | HP:0012206 | |
| HumanPheno | Abnormal sperm physiology | 2.52e-06 | 115 | 54 | 9 | HP:0034809 | |
| HumanPheno | Chronic sinusitis | 6.56e-06 | 69 | 54 | 7 | HP:0011109 | |
| HumanPheno | Male infertility | OFD1 DNAAF11 DNAH7 FSIP2 KCNU1 DNAH17 TTC12 VAMP7 DNAH5 DNAH11 | 5.35e-05 | 209 | 54 | 10 | HP:0003251 |
| HumanPheno | Absent inner dynein arms | 9.04e-05 | 9 | 54 | 3 | HP:0012257 | |
| HumanPheno | Moderate to late preterm birth | 1.10e-04 | 2 | 54 | 2 | HP:0025664 | |
| HumanPheno | Peribronchovascular interstitial thickening | 1.48e-04 | 49 | 54 | 5 | HP:0025177 | |
| HumanPheno | Ectopic pregnancy | 1.48e-04 | 49 | 54 | 5 | HP:0031456 | |
| HumanPheno | Pulmonary situs ambiguus | 1.48e-04 | 49 | 54 | 5 | HP:0011617 | |
| HumanPheno | Abnormal pulmonary situs morphology | 1.48e-04 | 49 | 54 | 5 | HP:0011615 | |
| HumanPheno | Lithoptysis | 1.48e-04 | 49 | 54 | 5 | HP:0032543 | |
| HumanPheno | Decreased fertility in males | OFD1 DNAAF11 DNAH7 FSIP2 KCNU1 DNAH17 TTC12 VAMP7 DNAH5 DNAH11 | 1.49e-04 | 236 | 54 | 10 | HP:0012041 |
| HumanPheno | Atrial situs ambiguous | 1.64e-04 | 50 | 54 | 5 | HP:0011539 | |
| HumanPheno | Abnormal respiratory epithelium morphology | 1.91e-04 | 28 | 54 | 4 | HP:0012253 | |
| HumanPheno | Abnormal respiratory motile cilium morphology | 1.91e-04 | 28 | 54 | 4 | HP:0005938 | |
| HumanPheno | Chronic otitis media | 2.03e-04 | 156 | 54 | 8 | HP:0000389 | |
| HumanPheno | Abnormal inferior vena cava morphology | 2.16e-04 | 53 | 54 | 5 | HP:0025576 | |
| HumanPheno | Abnormal atrial arrangement | 2.36e-04 | 54 | 54 | 5 | HP:0011535 | |
| HumanPheno | Coiled sperm flagella | 3.26e-04 | 32 | 54 | 4 | HP:0032560 | |
| MousePheno | abnormal aortic arch morphology | 4.44e-05 | 119 | 111 | 7 | MP:0004113 | |
| MousePheno | complete atrioventricular septal defect | 4.92e-05 | 26 | 111 | 4 | MP:0010413 | |
| MousePheno | biventricular, ambiguous atrioventricular connection | 6.25e-05 | 2 | 111 | 2 | MP:0011511 | |
| MousePheno | atrial septal defect | 6.99e-05 | 88 | 111 | 6 | MP:0010403 | |
| MousePheno | abnormal respiratory motile cilium physiology | 7.67e-05 | 29 | 111 | 4 | MP:0011055 | |
| MousePheno | pulmonary artery hypoplasia | 7.68e-05 | 11 | 111 | 3 | MP:0010460 | |
| MousePheno | abnormal subclavian artery morphology | 7.98e-05 | 56 | 111 | 5 | MP:0003395 | |
| MousePheno | abnormal thoracic aorta morphology | 9.43e-05 | 134 | 111 | 7 | MP:0010468 | |
| MousePheno | right aortic arch | 1.11e-04 | 60 | 111 | 5 | MP:0004158 | |
| MousePheno | abnormal lung lobe morphology | 1.29e-04 | 33 | 111 | 4 | MP:0010975 | |
| MousePheno | abnormal cilium morphology | DYNC2H1 NUP210L DNAAF11 FSIP2 GRXCR2 CFAP54 DNAH17 VPS13A DNAH5 TBC1D21 HERC4 DNAH11 | 1.65e-04 | 433 | 111 | 12 | MP:0013202 |
| MousePheno | abnormal motile cilium morphology | DYNC2H1 NUP210L DNAAF11 FSIP2 CFAP54 DNAH17 VPS13A DNAH5 TBC1D21 HERC4 DNAH11 | 1.71e-04 | 370 | 111 | 11 | MP:0013206 |
| MousePheno | abnormal cornea posterior stroma morphology | 1.86e-04 | 3 | 111 | 2 | MP:0003094 | |
| MousePheno | biventricular, discordant atrioventricular connection | 1.86e-04 | 3 | 111 | 2 | MP:0011510 | |
| MousePheno | abnormal interatrial septum morphology | 2.06e-04 | 107 | 111 | 6 | MP:0000282 | |
| MousePheno | abnormal cranium morphology | MBTD1 DYNC2H1 IRF6 DNAAF11 FOXN3 DCN NXN FREM1 TGFB2 CFAP54 TET1 DNAH5 NOS2 GABPA HTT DNAH11 MGRN1 | 2.21e-04 | 813 | 111 | 17 | MP:0000438 |
| MousePheno | abnormal craniofacial bone morphology | MBTD1 DYNC2H1 IRF6 DNAAF11 FOXN3 DCN NXN FREM1 TGFB2 CFAP54 TET1 DNAH5 NOS2 GABPA HTT DNAH11 MGRN1 | 2.70e-04 | 827 | 111 | 17 | MP:0002116 |
| MousePheno | immotile respiratory cilia | 3.06e-04 | 17 | 111 | 3 | MP:0011649 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.19e-06 | 14 | 131 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.19e-06 | 14 | 131 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.19e-06 | 14 | 131 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.19e-06 | 14 | 131 | 4 | PF08393 | |
| Domain | MT | 2.19e-06 | 14 | 131 | 4 | PF12777 | |
| Domain | AAA_8 | 2.19e-06 | 14 | 131 | 4 | PF12780 | |
| Domain | DHC_fam | 2.97e-06 | 15 | 131 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.97e-06 | 15 | 131 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.97e-06 | 15 | 131 | 4 | IPR004273 | |
| Domain | LRR | 1.23e-05 | 201 | 131 | 9 | PS51450 | |
| Domain | UDPGT | 1.26e-05 | 21 | 131 | 4 | PF00201 | |
| Domain | UDPGT | 1.26e-05 | 21 | 131 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 1.26e-05 | 21 | 131 | 4 | IPR002213 | |
| Domain | DHC_N1 | 1.84e-05 | 8 | 131 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.84e-05 | 8 | 131 | 3 | IPR013594 | |
| Domain | LRR_1 | 2.44e-05 | 219 | 131 | 9 | PF00560 | |
| Domain | CRAL_TRIO | 3.58e-05 | 27 | 131 | 4 | PS50191 | |
| Domain | CRAL-TRIO_dom | 4.15e-05 | 28 | 131 | 4 | IPR001251 | |
| Domain | Spectrin_repeat | 4.79e-05 | 29 | 131 | 4 | IPR002017 | |
| Domain | SPEC | 7.14e-05 | 32 | 131 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.14e-05 | 32 | 131 | 4 | IPR018159 | |
| Domain | RhoGEF | 1.15e-04 | 68 | 131 | 5 | SM00325 | |
| Domain | ATPase_dyneun-rel_AAA | 1.16e-04 | 14 | 131 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.16e-04 | 14 | 131 | 3 | PF07728 | |
| Domain | Leu-rich_rpt | 1.26e-04 | 271 | 131 | 9 | IPR001611 | |
| Domain | RhoGEF | 1.32e-04 | 70 | 131 | 5 | PF00621 | |
| Domain | DH_2 | 1.32e-04 | 70 | 131 | 5 | PS50010 | |
| Domain | - | 1.41e-04 | 71 | 131 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 1.41e-04 | 71 | 131 | 5 | IPR000219 | |
| Domain | VPS13 | 1.46e-04 | 3 | 131 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.46e-04 | 3 | 131 | 2 | PF16910 | |
| Domain | VPS13 | 1.46e-04 | 3 | 131 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.46e-04 | 3 | 131 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.46e-04 | 3 | 131 | 2 | IPR031642 | |
| Domain | LRR_8 | 2.05e-04 | 171 | 131 | 7 | PF13855 | |
| Domain | SHR-BD | 2.90e-04 | 4 | 131 | 2 | IPR009543 | |
| Domain | VPS13_C | 2.90e-04 | 4 | 131 | 2 | PF16909 | |
| Domain | VPS13_C | 2.90e-04 | 4 | 131 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.90e-04 | 4 | 131 | 2 | PF06650 | |
| Domain | - | 4.42e-04 | 321 | 131 | 9 | 3.80.10.10 | |
| Domain | L_dom-like | 5.16e-04 | 328 | 131 | 9 | IPR032675 | |
| Domain | LRRNT | 5.19e-04 | 53 | 131 | 4 | PF01462 | |
| Domain | Spectrin | 5.39e-04 | 23 | 131 | 3 | PF00435 | |
| Domain | ARM-type_fold | 6.53e-04 | 339 | 131 | 9 | IPR016024 | |
| Domain | SEC14 | 6.93e-04 | 25 | 131 | 3 | SM00516 | |
| Domain | DH_1 | 1.00e-03 | 63 | 131 | 4 | PS00741 | |
| Domain | PH | 1.17e-03 | 229 | 131 | 7 | PF00169 | |
| Domain | Chorein_N | 1.33e-03 | 8 | 131 | 2 | PF12624 | |
| Domain | VPS13_N | 1.33e-03 | 8 | 131 | 2 | IPR026854 | |
| Domain | LRR_TYP | 1.57e-03 | 177 | 131 | 6 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.57e-03 | 177 | 131 | 6 | IPR003591 | |
| Domain | Olfact_rcpt | OR6N2 OR4K13 OR5I1 OR10G4 OR51F2 OR4C15 OR10G9 OR10G8 OR4K15 | 1.83e-03 | 393 | 131 | 9 | IPR000725 |
| Domain | GDS_CDC24_CS | 2.56e-03 | 39 | 131 | 3 | IPR001331 | |
| Domain | CRAL_TRIO_2 | 3.08e-03 | 12 | 131 | 2 | PF13716 | |
| Domain | PH_dom-like | 3.14e-03 | 426 | 131 | 9 | IPR011993 | |
| Domain | PH | 3.50e-03 | 278 | 131 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 3.56e-03 | 279 | 131 | 7 | PS50003 | |
| Domain | PH_domain | 3.64e-03 | 280 | 131 | 7 | IPR001849 | |
| Domain | Cys-rich_flank_reg_C | 3.71e-03 | 90 | 131 | 4 | IPR000483 | |
| Domain | LRRCT | 3.71e-03 | 90 | 131 | 4 | SM00082 | |
| Domain | HEAT | 4.63e-03 | 48 | 131 | 3 | PF02985 | |
| Domain | TBC | 4.91e-03 | 49 | 131 | 3 | SM00164 | |
| Domain | LRRNT | 5.02e-03 | 98 | 131 | 4 | IPR000372 | |
| Domain | LRRNT | 5.02e-03 | 98 | 131 | 4 | SM00013 | |
| Domain | Ald_DH_CS_GLU | 5.49e-03 | 16 | 131 | 2 | IPR029510 | |
| Domain | RabGAP-TBC | 6.12e-03 | 53 | 131 | 3 | PF00566 | |
| Domain | TPR_8 | 6.12e-03 | 53 | 131 | 3 | PF13181 | |
| Domain | MMR_HSR1 | 6.20e-03 | 17 | 131 | 2 | PF01926 | |
| Domain | Ald_DH_CS_CYS | 6.20e-03 | 17 | 131 | 2 | IPR016160 | |
| Domain | - | 6.37e-03 | 391 | 131 | 8 | 2.30.29.30 | |
| Domain | Rab-GTPase-TBC_dom | 6.78e-03 | 55 | 131 | 3 | IPR000195 | |
| Domain | TBC_RABGAP | 6.78e-03 | 55 | 131 | 3 | PS50086 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 6.94e-03 | 18 | 131 | 2 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 6.94e-03 | 18 | 131 | 2 | PS00687 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.13e-06 | 25 | 108 | 5 | M605 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.77e-06 | 175 | 108 | 9 | MM15599 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K | 8.60e-06 | 6 | 108 | 3 | M27929 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.17e-05 | 184 | 108 | 9 | M41809 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.30e-05 | 45 | 108 | 5 | M47670 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.58e-05 | 23 | 108 | 4 | MM16639 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.08e-05 | 24 | 108 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.64e-05 | 25 | 108 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 3.64e-05 | 25 | 108 | 4 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 4.28e-05 | 26 | 108 | 4 | M39404 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.69e-05 | 52 | 108 | 5 | M14171 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 4.99e-05 | 27 | 108 | 4 | M47755 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 5.79e-05 | 28 | 108 | 4 | M19580 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 8.29e-05 | 94 | 108 | 6 | MM15598 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.08e-04 | 142 | 108 | 7 | MM15576 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.28e-04 | 64 | 108 | 5 | M9488 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.46e-04 | 149 | 108 | 7 | M41805 | |
| Pathway | PID_IL23_PATHWAY | 1.77e-04 | 37 | 108 | 4 | M196 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.09e-04 | 71 | 108 | 5 | MM15604 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.18e-04 | 39 | 108 | 4 | MM15695 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.55e-04 | 74 | 108 | 5 | M41814 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.65e-04 | 41 | 108 | 4 | M7399 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 2.75e-04 | 17 | 108 | 3 | M27918 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.19e-04 | 43 | 108 | 4 | M47669 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.49e-04 | 44 | 108 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.81e-04 | 45 | 108 | 4 | MM15694 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 5.26e-04 | 21 | 108 | 3 | M8601 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 5.26e-04 | 21 | 108 | 3 | MM1463 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 TRIO KALRN MCF2 PIK3CA PIK3R1 ITSN2 DOCK7 PKN2 MCF2L ALDH3A2 | 5.38e-04 | 439 | 108 | 11 | MM15595 |
| Pathway | PID_HEDGEHOG_2PATHWAY | 6.06e-04 | 22 | 108 | 3 | M211 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 6.17e-04 | 51 | 108 | 4 | M17726 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 TRIO KALRN MCF2 PIK3CA PIK3R1 ITSN2 DOCK7 PKN2 MCF2L ALDH3A2 | 6.61e-04 | 450 | 108 | 11 | M27078 |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 6.65e-04 | 52 | 108 | 4 | MM14743 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 6.93e-04 | 23 | 108 | 3 | M18719 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 6.93e-04 | 23 | 108 | 3 | MM1480 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 7.87e-04 | 24 | 108 | 3 | M11420 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 7.87e-04 | 24 | 108 | 3 | MM1373 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 8.23e-04 | 55 | 108 | 4 | M14933 | |
| Pathway | BIOCARTA_SLRP_PATHWAY | 8.55e-04 | 6 | 108 | 2 | M22071 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 8.55e-04 | 6 | 108 | 2 | M27741 | |
| Pathway | BIOCARTA_SLRP_PATHWAY | 8.55e-04 | 6 | 108 | 2 | MM1581 | |
| Pathway | REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING | 8.55e-04 | 6 | 108 | 2 | MM15489 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 8.90e-04 | 25 | 108 | 3 | M274 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 9.42e-04 | 57 | 108 | 4 | M27381 | |
| Pathway | PID_SHP2_PATHWAY | 9.42e-04 | 57 | 108 | 4 | M100 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.07e-03 | 59 | 108 | 4 | M11215 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K | 1.19e-03 | 7 | 108 | 2 | M27910 | |
| Pathway | REACTOME_SIGNALING_BY_LTK_IN_CANCER | 1.19e-03 | 7 | 108 | 2 | M48255 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 1.19e-03 | 7 | 108 | 2 | MM1487 | |
| Pathway | PID_TRKR_PATHWAY | 1.22e-03 | 61 | 108 | 4 | M187 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.22e-03 | 155 | 108 | 6 | M41808 | |
| Pathway | KEGG_COLORECTAL_CANCER | 1.29e-03 | 62 | 108 | 4 | M14631 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.53e-03 | 30 | 108 | 3 | MM15236 | |
| Pathway | PID_CDC42_REG_PATHWAY | 1.53e-03 | 30 | 108 | 3 | M83 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 1.58e-03 | 8 | 108 | 2 | MM14776 | |
| Pathway | BIOCARTA_CDC42RAC_PATHWAY | 1.58e-03 | 8 | 108 | 2 | M5291 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING | 1.58e-03 | 8 | 108 | 2 | MM14532 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.68e-03 | 31 | 108 | 3 | M27510 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.72e-03 | 67 | 108 | 4 | MM15345 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 1.82e-03 | 68 | 108 | 4 | M39456 | |
| Pathway | PID_NETRIN_PATHWAY | 1.85e-03 | 32 | 108 | 3 | M108 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.92e-03 | 69 | 108 | 4 | MM15596 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 2.02e-03 | 9 | 108 | 2 | M22029 | |
| Pathway | BIOCARTA_PLC_PATHWAY | 2.02e-03 | 9 | 108 | 2 | MM1551 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 2.02e-03 | 9 | 108 | 2 | M26935 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 2.02e-03 | 9 | 108 | 2 | M714 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 2.02e-03 | 9 | 108 | 2 | MM14548 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.03e-03 | 70 | 108 | 4 | M41806 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.03e-03 | 70 | 108 | 4 | MM14824 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.03e-03 | 70 | 108 | 4 | M16794 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.03e-03 | 70 | 108 | 4 | MM15597 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.25e-03 | 72 | 108 | 4 | M9257 | |
| Pubmed | 1.65e-09 | 14 | 136 | 5 | 9373155 | ||
| Pubmed | 7.76e-09 | 7 | 136 | 4 | 26074487 | ||
| Pubmed | 1.55e-08 | 8 | 136 | 4 | 32093886 | ||
| Pubmed | Association of the proto-oncogene product dbl with G protein betagamma subunits. | 5.82e-07 | 5 | 136 | 3 | 10518015 | |
| Pubmed | 2.02e-06 | 7 | 136 | 3 | 31178125 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 18719240 | ||
| Pubmed | 3.23e-06 | 8 | 136 | 3 | 20142249 | ||
| Pubmed | DYNC2H1 SYTL2 TNIP1 VPS13D THADA PER3 SACS DNAH17 TXNDC16 NCEH1 SPIDR | 4.12e-06 | 493 | 136 | 11 | 15368895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 CDS1 CAND1 NEK6 TRIO GRIK1 FOXN3 NXN THADA TBC1D1 TTC12 VPS35L MKLN1 SPIDR MCF2L USP15 CDH15 HTT MGRN1 | 5.75e-06 | 1489 | 136 | 19 | 28611215 |
| Pubmed | ZMYND10 functions in a chaperone relay during axonemal dynein assembly. | 6.88e-06 | 10 | 136 | 3 | 29916806 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.25e-05 | 12 | 136 | 3 | 20308471 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 18079394 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 25275137 | ||
| Pubmed | The COOH-terminal domain of huntingtin interacts with RhoGEF kalirin and modulates cell survival. | 1.52e-05 | 2 | 136 | 2 | 29789657 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 29983910 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28381646 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26122737 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32660355 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19036156 | ||
| Pubmed | Retinoic acid coordinates somitogenesis and left-right patterning in vertebrate embryos. | 1.52e-05 | 2 | 136 | 2 | 15889094 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 1909870 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24121496 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 9285789 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 26663310 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 24267955 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28630349 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22170718 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 23412898 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 32357925 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 36934165 | ||
| Pubmed | PIK3R1 underexpression is an independent prognostic marker in breast cancer. | 1.52e-05 | 2 | 136 | 2 | 24229379 | |
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 1.52e-05 | 2 | 136 | 2 | 3105095 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17848572 | ||
| Pubmed | Quantitative analysis of type I collagen fibril regulation by lumican and decorin using AFM. | 1.52e-05 | 2 | 136 | 2 | 23747391 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28789706 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27496708 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22064833 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 1.52e-05 | 2 | 136 | 2 | 26858404 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 17698910 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 38267530 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 9325061 | ||
| Pubmed | A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane. | 1.52e-05 | 2 | 136 | 2 | 19805105 | |
| Pubmed | Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases. | 1.52e-05 | 2 | 136 | 2 | 22120714 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 38282619 | ||
| Pubmed | Decorin-An Antagonist of TGF-β in Astrocytes of the Optic Nerve. | 1.52e-05 | 2 | 136 | 2 | 34299278 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 27644884 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 7929193 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28676499 | ||
| Pubmed | Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha. | 1.52e-05 | 2 | 136 | 2 | 18418043 | |
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 1.52e-05 | 2 | 136 | 2 | 3117546 | |
| Pubmed | Role of Per3, a circadian clock gene, in embryonic development of mouse cerebral cortex. | 1.52e-05 | 2 | 136 | 2 | 30971765 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 22355357 | ||
| Pubmed | Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. | 1.52e-05 | 2 | 136 | 2 | 1322797 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 19410201 | ||
| Pubmed | Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients. | 1.52e-05 | 2 | 136 | 2 | 29636477 | |
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 28228532 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 16636057 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 34507989 | ||
| Pubmed | 1.52e-05 | 2 | 136 | 2 | 15666817 | ||
| Pubmed | 1.63e-05 | 13 | 136 | 3 | 17884984 | ||
| Pubmed | 2.43e-05 | 87 | 136 | 5 | 37495603 | ||
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 4.48e-05 | 50 | 136 | 4 | 19807924 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 10358930 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 19572376 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 16043515 | ||
| Pubmed | PI3K/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis. | 4.54e-05 | 3 | 136 | 2 | 21442372 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 31801062 | ||
| Pubmed | Pancreatic tumor cells influence the composition of the extracellular matrix. | 4.54e-05 | 3 | 136 | 2 | 15336555 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 26385605 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 8333863 | ||
| Pubmed | M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion. | 4.54e-05 | 3 | 136 | 2 | 17332503 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 29138287 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 11207258 | ||
| Pubmed | Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85α Homodimer. | 4.54e-05 | 3 | 136 | 2 | 26475863 | |
| Pubmed | PI3K activation is enhanced by FOXM1D binding to p110 and p85 subunits. | 4.54e-05 | 3 | 136 | 2 | 32606397 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 27377816 | ||
| Pubmed | PI3K mediates stretch-induced COX-2 expression during urinary tract obstruction. | 4.54e-05 | 3 | 136 | 2 | 22998445 | |
| Pubmed | Mahogunin ring finger 1 suppresses misfolded polyglutamine aggregation and cytotoxicity. | 4.54e-05 | 3 | 136 | 2 | 24769000 | |
| Pubmed | Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. | 4.54e-05 | 3 | 136 | 2 | 14729945 | |
| Pubmed | ΔNp63α/IRF6 interplay activates NOS2 transcription and induces autophagy upon tobacco exposure. | 4.54e-05 | 3 | 136 | 2 | 21129360 | |
| Pubmed | Activated G alpha q inhibits p110 alpha phosphatidylinositol 3-kinase and Akt. | 4.54e-05 | 3 | 136 | 2 | 12704201 | |
| Pubmed | Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. | 4.54e-05 | 3 | 136 | 2 | 11029009 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 25304290 | ||
| Pubmed | The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma. | 4.54e-05 | 3 | 136 | 2 | 21595858 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 16150444 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 4.54e-05 | 3 | 136 | 2 | 26163549 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 7957566 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 7835904 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 20736324 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 10579793 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 14511371 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 28459201 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 19819947 | ||
| Pubmed | Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients. | 4.54e-05 | 3 | 136 | 2 | 29867136 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 20713702 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 28882566 | ||
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 30630630 | ||
| Pubmed | Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly. | 4.54e-05 | 3 | 136 | 2 | 25886697 | |
| Pubmed | 4.54e-05 | 3 | 136 | 2 | 23643389 | ||
| Pubmed | TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes. | 4.54e-05 | 3 | 136 | 2 | 33087848 | |
| Cytoband | 4q13 | 1.13e-05 | 15 | 136 | 3 | 4q13 | |
| GeneFamily | Dyneins, axonemal | 1.30e-06 | 17 | 90 | 4 | 536 | |
| GeneFamily | UDP glucuronosyltransferases | 1.86e-05 | 32 | 90 | 4 | 363 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.92e-05 | 66 | 90 | 5 | 722 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 1.57e-03 | 12 | 90 | 2 | 573 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 8.66e-06 | 197 | 135 | 8 | M8426 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 1.38e-05 | 210 | 135 | 8 | MM958 | |
| Coexpression | YANAGIHARA_ESX1_TARGETS | 1.45e-05 | 29 | 135 | 4 | M1538 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.83e-05 | 169 | 135 | 7 | M39230 | |
| Coexpression | RODRIGUES_DCC_TARGETS_DN | 3.60e-05 | 119 | 135 | 6 | M15927 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | DNAAF11 DNAI3 DNAH7 ANKRD18B CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 4.07e-05 | 317 | 135 | 9 | M40298 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.07e-06 | 203 | 124 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 3.18e-06 | 18 | 124 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k4_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | MBTD1 CDS1 ARHGAP24 IRF6 MSH3 PER3 PIK3CA PTS TBC1D1 VPS13A MKLN1 NCEH1 PKN2 TTLL10 IL6ST MGRN1 | 1.15e-05 | 774 | 124 | 16 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | MBTD1 MSH3 PER3 PIK3CA VPS13A MKLN1 NCEH1 PKN2 TTLL10 IL6ST MGRN1 | 1.28e-05 | 375 | 124 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | KALRN SYTL2 DCN FREM1 TGFB2 ALDH1A2 PIK3R1 LUM SLITRK6 LRRC17 | 2.92e-05 | 337 | 124 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 3.70e-05 | 156 | 124 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 3.98e-05 | 33 | 124 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_100 | 5.65e-05 | 36 | 124 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TRIO SRP72 GRIK1 DCN TGFB2 VPS13D ALDH1A2 PIK3R1 TET1 FLRT1 LUM CNOT4 HTT KNL1 LRRC17 | 5.84e-05 | 790 | 124 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.93e-05 | 168 | 124 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_200 | 6.30e-05 | 37 | 124 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_100 | 6.41e-05 | 72 | 124 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 8.17e-05 | 122 | 124 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.35e-05 | 125 | 124 | 6 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_100 | 1.49e-04 | 18 | 124 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.61e-04 | 336 | 124 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.67e-04 | 265 | 124 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ARHGAP24 NEK6 SYTL2 HPSE2 DCN FREM1 TGFB2 ALDH1A2 PLXNC1 TET1 C7 LUM KNL1 LRRC17 | 1.80e-04 | 777 | 124 | 14 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.81e-04 | 201 | 124 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | SYTL2 DCN FREM1 ALDH1A2 PLXNC1 PIK3R1 ASNS SPIDR LUM SLITRK6 | 1.92e-04 | 423 | 124 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 2.06e-04 | 20 | 124 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200 | 2.27e-04 | 147 | 124 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.37e-04 | 354 | 124 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | TRIO NTRK3 GRIK1 DCN TGFB2 ALDH1A2 PIK3R1 TET1 LUM SLITRK6 CNOT4 HTT KNL1 LRRC17 | 2.40e-04 | 799 | 124 | 14 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | TRIO SRP72 GRIK1 DCN TGFB2 ALDH1A2 PIK3CA PIK3R1 TET1 FLRT1 LUM CNOT4 HTT LRRC17 | 2.46e-04 | 801 | 124 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 2.47e-04 | 356 | 124 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 2.74e-04 | 361 | 124 | 9 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | KALRN SYTL2 DCN DNAH7 FREM1 TGFB2 ALDH1A2 PLXNC1 PIK3R1 ASNS SPIDR LUM SLITRK6 LRRC17 | 3.40e-04 | 827 | 124 | 14 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 3.70e-04 | 161 | 124 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.70e-04 | 226 | 124 | 7 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 4.22e-04 | 165 | 124 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 4.58e-04 | 26 | 124 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_200 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_top-relative-expression-ranked_200 | 4.64e-04 | 168 | 124 | 6 | gudmap_kidney_e15.5_Podocyte_MafB_200 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 5.70e-04 | 65 | 124 | 4 | BM Top 100 - myometrium | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | CDS1 OFD1 MCF2 SRP72 PIWIL2 DCN PER3 PLXNC1 PIK3R1 VAMP7 CNOT4 SMC1B LRRC17 | 5.74e-04 | 770 | 124 | 13 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 5.75e-04 | 175 | 124 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | MBTD1 CAND1 MSH3 DCN PIK3CA TBC1D1 VPS13A MKLN1 PKN2 LUM CNOT4 KNL1 MGRN1 | 5.88e-04 | 772 | 124 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.23e-04 | 117 | 124 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k3 | |
| CoexpressionAtlas | adrenal gland | 6.28e-04 | 247 | 124 | 7 | adrenal gland | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_100 | 6.76e-04 | 68 | 124 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_100 | 6.97e-04 | 7 | 124 | 2 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 7.03e-04 | 30 | 124 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_100 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | 7.25e-04 | 121 | 124 | 5 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | BM Top 100 - ovary | 7.54e-04 | 70 | 124 | 4 | BM Top 100 - ovary | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_top-relative-expression-ranked_100 | 7.54e-04 | 70 | 124 | 4 | gudmap_kidney_e13.5_Podocyte_MafB_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 7.88e-04 | 418 | 124 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | NEK6 KALRN DCN DNAH7 FREM1 TGFB2 ALDH1A2 PLXNC1 PIK3R1 ASNS SPIDR LUM LRRC17 | 7.89e-04 | 797 | 124 | 13 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | MBTD1 ENPP3 SRP72 GRIK1 PIWIL2 ALDH1A2 PLXNC1 PIK3R1 TET1 VAMP7 SPIDR CNOT4 SMC1B | 8.55e-04 | 804 | 124 | 13 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.60e-04 | 339 | 124 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.68e-04 | 261 | 124 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_100 | 8.83e-04 | 73 | 124 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_100 | 8.83e-04 | 73 | 124 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_100 | 9.26e-04 | 8 | 124 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_100 | 9.78e-04 | 75 | 124 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_100 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_200 | 9.85e-04 | 194 | 124 | 6 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.00e-03 | 130 | 124 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CDS1 REXO5 OFD1 ENPP3 PIWIL2 LYST URB1 DGKK ASNS TET1 VPS13A SMC1B HTT | 1.02e-03 | 820 | 124 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 1.03e-03 | 76 | 124 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.81e-10 | 190 | 136 | 10 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.67e-10 | 194 | 136 | 10 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CDS1 DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 4.91e-10 | 195 | 136 | 10 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | DYNC2H1 DNAAF11 DNAI3 DNAH7 ANKRD18B CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 6.28e-10 | 200 | 136 | 10 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.28e-10 | 200 | 136 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DYNC2H1 SYTL2 DNAAF11 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 2.67e-09 | 169 | 136 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 6.19e-09 | 186 | 136 | 9 | 76033438426d8f9c72cd6691a7baf92104c9f03d |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 7.45e-09 | 190 | 136 | 9 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 7.45e-09 | 190 | 136 | 9 | 833481ace2800354712e2ce709d5cdfd0aed3d42 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNC2H1 ITGA2 DNAI3 DNAH7 ANKRD18B CFAP54 TTLL10 DNAH5 DNAH11 | 8.54e-09 | 193 | 136 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.93e-09 | 194 | 136 | 9 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 8.93e-09 | 194 | 136 | 9 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.93e-09 | 194 | 136 | 9 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DYNC2H1 DNAI3 DNAH7 ANKRD18B CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 8.93e-09 | 194 | 136 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 9.34e-09 | 195 | 136 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 9.34e-09 | 195 | 136 | 9 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 9.77e-09 | 196 | 136 | 9 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 9.77e-09 | 196 | 136 | 9 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 1.02e-08 | 197 | 136 | 9 | 6865f4831eb23794fb88a8649d48d497bbae3f44 |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 1.02e-08 | 197 | 136 | 9 | 71fea4aa6ce96c7693fa94792d08770622873850 |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 1.02e-08 | 197 | 136 | 9 | e453d085182364ca347cbcc9dc995c62c3353016 |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 1.02e-08 | 197 | 136 | 9 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DYNC2H1 DNAAF11 DNAI3 DNAH7 CFAP54 TTLL10 DNAH5 NEK11 DNAH11 | 1.07e-08 | 198 | 136 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-08 | 199 | 136 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.16e-08 | 164 | 136 | 8 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.79e-08 | 167 | 136 | 8 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.75e-08 | 171 | 136 | 8 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.84e-08 | 178 | 136 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-07 | 185 | 136 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-07 | 189 | 136 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-07 | 191 | 136 | 8 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-07 | 191 | 136 | 8 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.46e-07 | 193 | 136 | 8 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-07 | 193 | 136 | 8 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.46e-07 | 193 | 136 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.46e-07 | 193 | 136 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-07 | 193 | 136 | 8 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.46e-07 | 193 | 136 | 8 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.52e-07 | 194 | 136 | 8 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.52e-07 | 194 | 136 | 8 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-07 | 194 | 136 | 8 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-07 | 195 | 136 | 8 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-07 | 195 | 136 | 8 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-07 | 195 | 136 | 8 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.64e-07 | 196 | 136 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 197 | 136 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-07 | 197 | 136 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-07 | 200 | 136 | 8 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-07 | 200 | 136 | 8 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-07 | 200 | 136 | 8 | 8441e289377215a6877640946fe3f6de1f456502 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-06 | 176 | 136 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-06 | 179 | 136 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-06 | 180 | 136 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 181 | 136 | 7 | 57994ff4ecffb15653aee00644d9f887f5e3461d | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 182 | 136 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 182 | 136 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-06 | 182 | 136 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-06 | 182 | 136 | 7 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 184 | 136 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 184 | 136 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 184 | 136 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.66e-06 | 185 | 136 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-06 | 186 | 136 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-06 | 187 | 136 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 1.84e-06 | 188 | 136 | 7 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.84e-06 | 188 | 136 | 7 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 189 | 136 | 7 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.91e-06 | 189 | 136 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 189 | 136 | 7 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-06 | 190 | 136 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-06 | 191 | 136 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.05e-06 | 191 | 136 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.12e-06 | 192 | 136 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.12e-06 | 192 | 136 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.19e-06 | 193 | 136 | 7 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.19e-06 | 193 | 136 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.27e-06 | 194 | 136 | 7 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.27e-06 | 194 | 136 | 7 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-06 | 195 | 136 | 7 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 195 | 136 | 7 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-06 | 195 | 136 | 7 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.35e-06 | 195 | 136 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 195 | 136 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 2.35e-06 | 195 | 136 | 7 | 3441381759cd00d125752401dc99b78be1c78f88 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-06 | 195 | 136 | 7 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.43e-06 | 196 | 136 | 7 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.43e-06 | 196 | 136 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.51e-06 | 197 | 136 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-06 | 197 | 136 | 7 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.51e-06 | 197 | 136 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.51e-06 | 197 | 136 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.60e-06 | 198 | 136 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.60e-06 | 198 | 136 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.69e-06 | 199 | 136 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-06 | 200 | 136 | 7 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.78e-06 | 200 | 136 | 7 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-06 | 200 | 136 | 7 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.78e-06 | 200 | 136 | 7 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.78e-06 | 200 | 136 | 7 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.78e-06 | 200 | 136 | 7 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| Drug | L-idaro-1,4-lactone | 5.77e-07 | 28 | 134 | 5 | CID000078997 | |
| Drug | urochloralic acid | 1.30e-06 | 59 | 134 | 6 | CID003036914 | |
| Drug | UDP-alpha-d-xylopyranose | 1.43e-06 | 60 | 134 | 6 | CID000001165 | |
| Drug | AC1NOWCJ | 1.85e-06 | 35 | 134 | 5 | CID005120112 | |
| Drug | Amobarbital | 1.98e-06 | 5 | 134 | 3 | ctd:D000654 | |
| Drug | C1 11-32 | 3.29e-06 | 18 | 134 | 4 | CID000443077 | |
| Drug | C11131 | 3.29e-06 | 18 | 134 | 4 | CID000443076 | |
| Drug | harmol | 3.65e-06 | 40 | 134 | 5 | CID000068094 | |
| Drug | Biliton | 4.14e-06 | 41 | 134 | 5 | CID000002974 | |
| Drug | T4-G | 4.15e-06 | 19 | 134 | 4 | CID000152424 | |
| Drug | estriol-16-glucuronide | 6.35e-06 | 21 | 134 | 4 | CID000122281 | |
| Drug | O-NO | 8.42e-06 | 123 | 134 | 7 | CID005494437 | |
| Drug | salicylamide | 9.16e-06 | 48 | 134 | 5 | CID000005147 | |
| Drug | estradiol-3-glucuronide | 9.31e-06 | 23 | 134 | 4 | CID000066651 | |
| Drug | 4-nitrophenol | 1.03e-05 | 177 | 134 | 8 | CID000000980 | |
| Drug | Hymecromone | 1.32e-05 | 25 | 134 | 4 | ctd:D006923 | |
| Drug | AC1NQGK1 | 1.36e-05 | 52 | 134 | 5 | CID005195977 | |
| Drug | 8-Bromo Cyclic Adenosine Monophosphate | NEK6 MCF2 ITGA2 NXN TGFB2 PTS ASNS UGT2B17 RORB LUM MCF2L UGT2B11 DNAH5 NOS2 LRRC17 | 1.47e-05 | 693 | 134 | 15 | ctd:D015124 |
| Drug | oxazepam | 1.50e-05 | 53 | 134 | 5 | CID000004616 | |
| Drug | licochalcone A | 1.81e-05 | 27 | 134 | 4 | ctd:C070840 | |
| Drug | butylated hydroxytoluene | 2.25e-05 | 143 | 134 | 7 | CID000031404 | |
| Drug | phenolphthalein | 2.34e-05 | 58 | 134 | 5 | CID000004764 | |
| Drug | 7-hydroxycoumarin glucuronide | 2.43e-05 | 29 | 134 | 4 | CID000125641 | |
| Drug | SN-38G | 2.54e-05 | 59 | 134 | 5 | CID000443154 | |
| Drug | hyaluronan | 2.65e-05 | 263 | 134 | 9 | CID000024759 | |
| Drug | Mtp-chol | 3.44e-05 | 2 | 134 | 2 | CID005487061 | |
| Drug | bicyclo[1.1.1]pentane | 3.44e-05 | 2 | 134 | 2 | CID000136153 | |
| Drug | 3-OHBaP | 3.50e-05 | 63 | 134 | 5 | CID000025890 | |
| Drug | R(-)-Denopamine | 4.11e-05 | 33 | 134 | 4 | CID000003818 | |
| Drug | AC1Q6OQG | 4.11e-05 | 33 | 134 | 4 | CID000009686 | |
| Drug | BP-3,6-quinol | 4.11e-05 | 33 | 134 | 4 | CID000119292 | |
| Drug | disulfiram | 4.26e-05 | 158 | 134 | 7 | CID000003117 | |
| Drug | pheophytin | 4.82e-05 | 284 | 134 | 9 | CID000000250 | |
| Drug | Meldola | 5.07e-05 | 68 | 134 | 5 | CID000081507 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 5.21e-05 | 35 | 134 | 4 | CID010436171 | |
| Drug | estrone-3-glucuronide | 5.21e-05 | 35 | 134 | 4 | CID000115255 | |
| Drug | l-borneol | 6.52e-05 | 37 | 134 | 4 | CID000010049 | |
| Drug | T6-7 | 6.92e-05 | 14 | 134 | 3 | CID000216324 | |
| Drug | glucosiduronate | 7.03e-05 | 171 | 134 | 7 | CID000000610 | |
| Drug | LIGA20 | 8.04e-05 | 39 | 134 | 4 | CID006441213 | |
| Drug | 7-hydroxycoumarin | 8.13e-05 | 75 | 134 | 5 | CID005281426 | |
| Drug | 16-epiestriol | 9.22e-05 | 77 | 134 | 5 | CID000003269 | |
| Drug | AC1L1K7T | HTR2A NTRK3 FOXN3 TGFB2 PIK3CA PIK3R1 UGT2B4 UGT2B15 UGT2B17 PKN2 LUM NOS2 IL6ST | 9.40e-05 | 632 | 134 | 13 | CID000005376 |
| Drug | testosterone glucuronide | 9.81e-05 | 41 | 134 | 4 | CID000108192 | |
| Drug | 2-AF | 9.81e-05 | 41 | 134 | 4 | CID000005800 | |
| Drug | (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE | 1.03e-04 | 3 | 134 | 2 | DB08059 | |
| Drug | AC1L1W6N | 1.03e-04 | 3 | 134 | 2 | CID000010897 | |
| Drug | aptiganel HCl | 1.03e-04 | 3 | 134 | 2 | CID011954290 | |
| Drug | santamarine | 1.03e-04 | 3 | 134 | 2 | CID000188297 | |
| Drug | 5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 1.15e-04 | 185 | 134 | 7 | 944_UP | |
| Drug | androsterone glucuronide | 1.18e-04 | 43 | 134 | 4 | CID000114833 | |
| Drug | 7,8-benzoquinoline | 1.18e-04 | 43 | 134 | 4 | CID000009191 | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 1.27e-04 | 188 | 134 | 7 | 7097_DN | |
| Drug | MS-222 | 1.30e-04 | 44 | 134 | 4 | CID000011400 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.31e-04 | 189 | 134 | 7 | CID000001413 | |
| Drug | DNCB | 1.31e-04 | 189 | 134 | 7 | CID000000006 | |
| Drug | 4-methylumbelliferone | 1.33e-04 | 132 | 134 | 6 | CID003364573 | |
| Drug | Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.36e-04 | 190 | 134 | 7 | 3331_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.45e-04 | 192 | 134 | 7 | 2865_DN | |
| Drug | 0316684-0000 [391209-55-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 7052_DN | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; HL60; HT_HG-U133A | 1.49e-04 | 193 | 134 | 7 | 2731_UP | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HG-U133A | 1.54e-04 | 194 | 134 | 7 | 1949_UP | |
| Drug | sodium cholate | ENPP3 DCN TGFB2 UGT2B4 UGT2B15 UGT2B17 NCEH1 MCF2L UGT2B11 HTT | 1.55e-04 | 408 | 134 | 10 | CID000000303 |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; HL60; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 2476_DN | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.64e-04 | 196 | 134 | 7 | 6653_DN | |
| Drug | chondroitin sulfate | MCF2 DCN LYST ITIH4 CHST4 UGT2B4 UGT2B15 UGT2B17 LUM UGT2B11 | 1.71e-04 | 413 | 134 | 10 | CID000024766 |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 2732_UP | |
| Drug | NS-398; Up 200; 10uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 6892_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 1518_UP | |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 7450_DN | |
| Drug | Bromperidol [10457-90-6]; Up 200; 9.6uM; HL60; HG-U133A | 1.75e-04 | 198 | 134 | 7 | 1723_UP | |
| Drug | troglitazone; Up 200; 10uM; HL60; HG-U133A | 1.75e-04 | 198 | 134 | 7 | 370_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 134 | 7 | 6444_DN | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 1.81e-04 | 199 | 134 | 7 | 4534_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; HL60; HG-U133A | 1.81e-04 | 199 | 134 | 7 | 1727_DN | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 1.81e-04 | 199 | 134 | 7 | 3822_UP | |
| Drug | ibuproxam | 2.05e-04 | 4 | 134 | 2 | CID000068704 | |
| Drug | 2,6-dibromophenol | 2.05e-04 | 4 | 134 | 2 | CID000011847 | |
| Drug | sulfate | ENPP3 HPSE2 GRIK1 ITGA2 DCN LYST ITIH4 ALDH1A2 ERAL1 CHST4 UGT2B4 UGT2B15 UGT2B17 PKN2 LUM UGT2B11 KLKB1 NOS2 IL6ST | 2.05e-04 | 1292 | 134 | 19 | CID000001117 |
| Drug | AC1L1OBF | 2.11e-04 | 20 | 134 | 3 | CID000032736 | |
| Drug | NSC625381 | 2.21e-04 | 145 | 134 | 6 | CID000002592 | |
| Drug | 2 E1 | 2.21e-04 | 145 | 134 | 6 | CID006102788 | |
| Drug | 2-naphthol | 2.25e-04 | 93 | 134 | 5 | CID000008663 | |
| Disease | X-19141 measurement | 2.27e-07 | 13 | 127 | 4 | EFO_0800799 | |
| Disease | X-24947 measurement | 2.25e-06 | 22 | 127 | 4 | EFO_0800910 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 6.42e-06 | 9 | 127 | 3 | EFO_0600040 | |
| Disease | Sjogren's Syndrome | 2.16e-05 | 13 | 127 | 3 | C1527336 | |
| Disease | Sicca Syndrome | 2.16e-05 | 13 | 127 | 3 | C0086981 | |
| Disease | Primary Ciliary Dyskinesia | 5.06e-05 | 47 | 127 | 4 | C4551720 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | cholic acid glucuronide measurement | 5.50e-05 | 3 | 127 | 2 | EFO_0800574 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 6.47e-05 | 50 | 127 | 4 | EFO_0010732 | |
| Disease | selenium measurement, response to dietary selenium supplementation | 8.41e-05 | 20 | 127 | 3 | EFO_0006331, EFO_0600021 | |
| Disease | androsterone glucuronide measurement | 8.41e-05 | 20 | 127 | 3 | EFO_0800317 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.07e-04 | 108 | 127 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | X-25937 measurement | 1.10e-04 | 4 | 127 | 2 | EFO_0800937 | |
| Disease | lumican measurement | 1.10e-04 | 4 | 127 | 2 | EFO_0021889 | |
| Disease | congenital diaphragmatic hernia (is_implicated_in) | 1.10e-04 | 4 | 127 | 2 | DOID:3827 (is_implicated_in) | |
| Disease | Kartagener syndrome (is_implicated_in) | 1.10e-04 | 4 | 127 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | Bronchiectasis | 1.13e-04 | 22 | 127 | 3 | C0006267 | |
| Disease | testosterone measurement | FOXN3 GALNT13 TGFB2 URB1 THADA PER3 DGKK UGT2B4 UGT2B15 UGT2B17 RORB UGT2B11 HERC4 LRRC36 KNL1 MGRN1 | 1.20e-04 | 1275 | 127 | 16 | EFO_0004908 |
| Disease | intermediate coronary syndrome (is_implicated_in) | 1.82e-04 | 5 | 127 | 2 | DOID:8805 (is_implicated_in) | |
| Disease | pack-years measurement, Barrett's esophagus | 1.82e-04 | 5 | 127 | 2 | EFO_0000280, EFO_0006526 | |
| Disease | response to bevacizumab, Proteinuria | 1.82e-04 | 5 | 127 | 2 | EFO_0005943, HP_0000093 | |
| Disease | eosinophil count | NEK6 RANBP6 TNIP1 HVCN1 DNAH7 ITIH4 STAT4 THADA ALDH1A2 PLXNC1 TBC1D1 VAMP7 PKN2 SPIDR USP15 NOS2 LRRC36 | 2.23e-04 | 1488 | 127 | 17 | EFO_0004842 |
| Disease | level of Phosphatidylcholine (18:2_18:2) in blood serum | 2.73e-04 | 6 | 127 | 2 | OBA_2045106 | |
| Disease | vanillylmandelate (VMA) measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0800119 | |
| Disease | cadherin-15 measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0020211 | |
| Disease | serum lipopolysaccharide activity | 3.81e-04 | 7 | 127 | 2 | EFO_0600064 | |
| Disease | X-24574 measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0800897 | |
| Disease | X-24418 measurement | 3.81e-04 | 7 | 127 | 2 | EFO_0800879 | |
| Disease | androsterone sulfate measurement | 3.87e-04 | 33 | 127 | 3 | EFO_0021117 | |
| Disease | Primary ciliary dyskinesia | 5.01e-04 | 36 | 127 | 3 | cv:C0008780 | |
| Disease | chemotherapy-induced alopecia, methylcobalamin deficiency type cblE | 5.06e-04 | 8 | 127 | 2 | EFO_0005400, MONDO_0009354 | |
| Disease | deoxycholic acid glucuronide measurement | 5.06e-04 | 8 | 127 | 2 | EFO_0800575 | |
| Disease | testis-expressed sequence 29 protein measurement | 5.06e-04 | 8 | 127 | 2 | EFO_0802125 | |
| Disease | level of Phosphatidylcholine (18:1_18:1) in blood serum | 5.06e-04 | 8 | 127 | 2 | OBA_2045099 | |
| Disease | vitamin D deficiency | 5.44e-04 | 37 | 127 | 3 | EFO_0003762 | |
| Disease | gastric carcinoma | 6.02e-04 | 89 | 127 | 4 | EFO_0000178 | |
| Disease | Lewy body dementia | 6.35e-04 | 39 | 127 | 3 | EFO_0006792 | |
| Disease | skin microbiome measurement | 6.35e-04 | 39 | 127 | 3 | EFO_0801228 | |
| Disease | Glaucoma | 6.49e-04 | 9 | 127 | 2 | C0017601 | |
| Disease | X-12844 measurement | 6.49e-04 | 9 | 127 | 2 | EFO_0021339 | |
| Disease | vitamin D measurement | 6.49e-04 | 336 | 127 | 7 | EFO_0004631 | |
| Disease | Crohn's disease | 6.66e-04 | 441 | 127 | 8 | EFO_0000384 | |
| Disease | Endometrioma | 6.76e-04 | 161 | 127 | 5 | C0269102 | |
| Disease | Endometriosis | 6.76e-04 | 161 | 127 | 5 | C0014175 | |
| Disease | dipeptidase 2 measurement | 8.09e-04 | 10 | 127 | 2 | EFO_0801528 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 8.09e-04 | 10 | 127 | 2 | EFO_0022090 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 9.86e-04 | 11 | 127 | 2 | EFO_0801531 | |
| Disease | Alcoholic Intoxication, Chronic | 1.10e-03 | 268 | 127 | 6 | C0001973 | |
| Disease | endometrial carcinoma (is_implicated_in) | 1.18e-03 | 12 | 127 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 1.18e-03 | 12 | 127 | 2 | EFO_0008258 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 1.18e-03 | 12 | 127 | 2 | OBA_2045157 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.18e-03 | 12 | 127 | 2 | EFO_0800291 | |
| Disease | free androgen index | 1.21e-03 | 374 | 127 | 7 | EFO_0007005 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.24e-03 | 49 | 127 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Ciliopathies | 1.33e-03 | 110 | 127 | 4 | C4277690 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 1.39e-03 | 13 | 127 | 2 | C0238288 | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.39e-03 | 13 | 127 | 2 | C2985290 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0800293 | |
| Disease | neuroblastoma | 1.62e-03 | 116 | 127 | 4 | EFO_0000621 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.62e-03 | 14 | 127 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Manganese Poisoning | 1.62e-03 | 14 | 127 | 2 | C0677050 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.62e-03 | 14 | 127 | 2 | OBA_2045100 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.62e-03 | 14 | 127 | 2 | EFO_0800283 | |
| Disease | sulfate measurement | 1.62e-03 | 14 | 127 | 2 | EFO_0007864 | |
| Disease | Hepatomegaly | 1.65e-03 | 54 | 127 | 3 | C0019209 | |
| Disease | intraocular pressure measurement | 1.66e-03 | 509 | 127 | 8 | EFO_0004695 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.72e-03 | 118 | 127 | 4 | EFO_0010119 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 1.86e-03 | 15 | 127 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | cutaneous psoriasis measurement, psoriasis | 2.12e-03 | 16 | 127 | 2 | EFO_0000676, EFO_0007773 | |
| Disease | Seasonal Affective Disorder | 2.12e-03 | 16 | 127 | 2 | C0085159 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.12e-03 | 16 | 127 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.12e-03 | 16 | 127 | 2 | C2713443 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 2.12e-03 | 16 | 127 | 2 | OBA_2045090 | |
| Disease | asthma (biomarker_via_orthology) | 2.12e-03 | 59 | 127 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.18e-03 | 307 | 127 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | Sjogren syndrome | 2.23e-03 | 60 | 127 | 3 | EFO_0000699 | |
| Disease | docosahexaenoic acid measurement | 2.25e-03 | 127 | 127 | 4 | EFO_0007761 | |
| Disease | Eye Abnormalities | 2.40e-03 | 17 | 127 | 2 | C0015393 | |
| Disease | rhinitis | 2.40e-03 | 17 | 127 | 2 | EFO_0008521 | |
| Disease | Limb Deformities, Congenital | 2.40e-03 | 17 | 127 | 2 | C0206762 | |
| Disease | Adenomatous Polyposis Coli | 2.40e-03 | 17 | 127 | 2 | C0032580 | |
| Disease | Fetal Alcohol Syndrome | 2.40e-03 | 17 | 127 | 2 | C0015923 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.45e-03 | 62 | 127 | 3 | EFO_0022339 | |
| Disease | cardiac troponin T measurement | 2.63e-03 | 219 | 127 | 5 | EFO_0005043 | |
| Disease | HbA1c measurement | 2.64e-03 | 675 | 127 | 9 | EFO_0004541 | |
| Disease | phosphatidylcholine 36:4 measurement | 2.69e-03 | 18 | 127 | 2 | EFO_0010382 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 2.69e-03 | 18 | 127 | 2 | EFO_0800288 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 2.69e-03 | 18 | 127 | 2 | OBA_2045065 | |
| Disease | Systemic Scleroderma | 3.00e-03 | 19 | 127 | 2 | C0036421 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 3.00e-03 | 19 | 127 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | etiocholanolone glucuronide measurement | 3.00e-03 | 19 | 127 | 2 | EFO_0800362 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.18e-03 | 229 | 127 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 3.32e-03 | 20 | 127 | 2 | OBA_2045071 | |
| Disease | cognitive function measurement | KALRN NUP210L NTRK3 TNIP1 DNAAF11 FOXN3 TBC1D1 ITSN2 PAXIP1 UGT2B15 FLRT1 DNAH5 CNOT4 GABPA | 3.54e-03 | 1434 | 127 | 14 | EFO_0008354 |
| Disease | amyotrophic lateral sclerosis | 3.62e-03 | 145 | 127 | 4 | MONDO_0004976 | |
| Disease | non-high density lipoprotein cholesterol measurement | MBTD1 FOXN3 THADA ALDH1A2 ITSN2 DOCK7 UGT2B15 UGT2B17 DNAH11 | 3.78e-03 | 713 | 127 | 9 | EFO_0005689 |
| Disease | colorectal carcinoma (is_implicated_in) | 4.01e-03 | 22 | 127 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | free cholesterol to total lipids in large LDL percentage | 4.04e-03 | 74 | 127 | 3 | EFO_0022280 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 4.09e-03 | 243 | 127 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | psoriasis, type 2 diabetes mellitus | 4.20e-03 | 75 | 127 | 3 | EFO_0000676, MONDO_0005148 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKQLKEAQVQYPLQT | 271 | P08243 | |
| ILQKNPVEQLLFAYK | 716 | Q96N23 | |
| LVLQPEQQLNIYKTL | 431 | Q92903 | |
| SLILLGKVQQLPKYT | 231 | Q9UNS2 | |
| PQIDKKQYNKILELI | 361 | O94788 | |
| VYVKNQLSGTLQIKP | 36 | Q9NZJ6 | |
| LQELIKAPSRYNIKI | 186 | P39086 | |
| QCQYKENKKPLQLIL | 396 | P28223 | |
| LQLILVNTIPALAYK | 406 | P28223 | |
| ENLNSIELNRKYIPK | 961 | A2A2Z9 | |
| LVQGYNKLKQTLLEV | 766 | Q96DT5 | |
| NKLKQTLLEVEYPLI | 771 | Q96DT5 | |
| ENTAKILAKLLPQYL | 141 | P51648 | |
| ISKNPVLVSQYEKLN | 16 | Q86W34 | |
| KKIVQEYPGNELLLV | 91 | Q8IWG1 | |
| VYELLLKVRPQQLVK | 156 | Q14624 | |
| EYQNKLIYLVPEKQL | 546 | Q9NZM3 | |
| LVDTPKQIQLLLQYL | 246 | Q9NVH2 | |
| KQIQLLLQYLKNDPR | 251 | Q9NVH2 | |
| LLQLIKINPTSSLYK | 111 | O75665 | |
| VLNPLIYSLRNKDVK | 286 | Q13606 | |
| KPKVYVQDILRQQLA | 1051 | P35228 | |
| PVQVQQYIKKLYILG | 876 | Q6ZW49 | |
| QEIRKILKNPSAQYV | 731 | P20585 | |
| INIIKTIQQGEIYKI | 301 | Q5KSL6 | |
| LLNPVVYTLRNKEVK | 281 | Q8NGN3 | |
| LNPLIYTFRNKEVKQ | 281 | Q8NGM1 | |
| PRKLITQDLVQEKYL | 241 | O15481 | |
| VLQKQPLVAKLAAYA | 106 | Q05BQ5 | |
| PQQRLNIKEIYKILH | 811 | Q16288 | |
| KIIIYTNNLKIIRTP | 121 | A6NFK2 | |
| YQGIEPKLNILEIVK | 101 | Q06546 | |
| VKLDLSYNKINQLRP | 271 | Q8N6Y2 | |
| ILDLKIIQPDKNNYA | 121 | Q96D96 | |
| PLKQKQIVDRVSYLL | 236 | O60291 | |
| LQELILSYNKIKTVP | 131 | Q96DD0 | |
| YPLKPEIILQKLQSN | 4106 | Q5CZC0 | |
| LQEITSQPKRQYLLL | 896 | Q86VP6 | |
| GQIPEIKQTLEILKY | 76 | P61758 | |
| TELQEQIYKLLLQPV | 401 | P56645 | |
| PFYLLVTTLNQKINK | 1156 | O60486 | |
| VTNEYLLQQLNKEPK | 686 | Q1X8D7 | |
| LNPIIYSVKIKQIQK | 301 | Q8NH61 | |
| LLNPIIYTLRNQEVK | 281 | Q8NH42 | |
| ILNPVIYTLRNKEVK | 281 | Q8NH41 | |
| TPLVKLERLYLSKNQ | 126 | P07585 | |
| KNKLKLQALIYPVLQ | 211 | Q6PIU2 | |
| QQKLLVPKESYVKLL | 386 | O75616 | |
| YVPNLLKSLRSQKIV | 231 | Q5GLZ8 | |
| QKDLNSKTILYIINP | 1696 | Q5H8C1 | |
| LIKPVQRITKYQLLL | 1411 | O60229 | |
| ILKIPYLDEQLQNLM | 281 | Q8NG66 | |
| LLKQLNHPNIIKYLD | 96 | Q9HC98 | |
| TILSKVPLENNYLKN | 2311 | Q8NG31 | |
| VPLENNYLKNVVKQI | 2316 | Q8NG31 | |
| IIQILQSHNKVYLPK | 446 | A8MYU2 | |
| LLNPVVYTLRNKEVK | 281 | Q8NGN5 | |
| ESLAQYNPKLDVKLL | 411 | P27986 | |
| KDYIQLKSLLQPIRI | 281 | Q8WWQ2 | |
| KQQLRKLLYPLQEVE | 41 | Q8N3Z3 | |
| KADNLVNLKIPLLYD | 921 | P17301 | |
| DKLSQYLIQLVQVLK | 626 | P42336 | |
| QPLQEVLLLKTKIRY | 86 | A8MZH6 | |
| LENYVKNLEVPVKII | 166 | Q8IUC8 | |
| NPIIYSLRNKEIIKA | 286 | Q8NGY6 | |
| KQVKSLPVVNYNLLK | 251 | Q8N264 | |
| NYEIIPNQIKKALEL | 1951 | Q8NCM8 | |
| SNLPRLQLELYKEIK | 161 | P42858 | |
| LTLRYLVPLLQQQVK | 316 | P42858 | |
| NPSIKSVIILKYNIQ | 246 | P40189 | |
| QPLINRKIPQLYKAV | 2106 | Q96N67 | |
| TPKTFLEQIKLYQNL | 3016 | Q9UFH2 | |
| YQDKVQPVSEILQLK | 851 | O14638 | |
| IDPEYRQNLIQALKK | 191 | O00409 | |
| VFVLKYLQKTQQLSP | 1156 | Q8IZJ3 | |
| TNLPQVIKQKLTPLY | 411 | P10643 | |
| LNQLNKEIYKPLLIN | 1991 | Q8WXX0 | |
| LKILYLQNNLIGKIE | 46 | Q86X45 | |
| LVELDLSYNKLKNIP | 256 | P51884 | |
| QDVLQIYVKTLPILL | 771 | Q99698 | |
| KNLQPTEYKTIQGIL | 1791 | Q99698 | |
| KPVQRITKYQLLLKE | 766 | O15068 | |
| PVQRITKYQLLLKEL | 631 | P10911 | |
| AIELLKKALEYIPNN | 266 | P09913 | |
| LIKLQAPLNYTEFQK | 486 | P03952 | |
| IEVYKLKQLKQPIDI | 156 | Q9UK59 | |
| PQDLKTKVNVQVIYL | 71 | Q9NZU1 | |
| TQDYLNPIILIKLVQ | 2136 | Q9NZJ4 | |
| LPYPLVQIKSDKQQL | 61 | P55291 | |
| SNQIPELYLKLLKLE | 821 | B7ZC32 | |
| QRESLPIYKLKEQLV | 561 | Q14562 | |
| ATQYPQLLEIKKQLN | 1396 | Q8TE73 | |
| LTSIIYQNKDIQPIK | 436 | Q5VU65 | |
| LLNPVVYTLRNKEVK | 281 | Q8NGN4 | |
| PDIKDNIVAQLKQLY | 426 | O14896 | |
| PDKSTLLKQYENLIL | 116 | Q6ZR62 | |
| LVVKKTLNPVYNEIL | 686 | Q9HCH5 | |
| QIHYIKQIVPLLEKA | 51 | Q6YHU6 | |
| LKVLYLNNNLLQVLP | 461 | Q9H5Y7 | |
| IQKIYDKDPLGNVLI | 126 | Q8IYX1 | |
| EQYKLLIKALQLSEP | 176 | Q9H061 | |
| VLAYTVREQQLKLPK | 346 | Q6ZMQ8 | |
| QLIQPIAEKIIAKYK | 346 | Q6DKJ4 | |
| QYLILKLERPAIVQN | 56 | Q9UL63 | |
| QLKTVANYEIPQLQK | 821 | Q8TC59 | |
| LQVKQARVNIQKYVP | 206 | O75343 | |
| LPQKIIYLNQLLQED | 36 | Q9UL46 | |
| QVYIITKPELQNKLI | 41 | Q8WTW4 | |
| LKYSLEQRLNEVPKN | 271 | Q16513 | |
| LQLYNQIIKLKPTDV | 246 | O76094 | |
| KILGKDFQQYLPLVI | 621 | O60518 | |
| LNNIKLLNKIYEAQP | 391 | O60287 | |
| LTQLASIIKINYIKP | 1081 | Q8NFU7 | |
| QSQLEIYKTIQSLPK | 251 | Q8NCG5 | |
| VYKPLSQEELQRIKN | 66 | O95628 | |
| VPEQRIELYQILKSK | 161 | P61812 | |
| LRQKVKYLQDQLSPL | 391 | Q15025 | |
| VNPQYKKAILTLVKQ | 641 | Q9P2K2 | |
| DLKINLKASYIIVPQ | 646 | Q96RL7 | |
| DSYPQLQLIIKKVIA | 541 | Q7Z3J2 | |
| LNALKTVINDPLYKE | 426 | P06133 | |
| SVETLLNQKRPQYIK | 286 | Q8NDV3 | |
| ATVIYQKPQLKSLLL | 651 | Q14159 | |
| LLIKLPELNYQVKVK | 346 | Q14765 | |
| KAAINLQDDPIIQKY | 166 | Q96IC2 | |
| DVPYKELLKQLTSQQ | 831 | Q86TI0 | |
| LIEPRKVQKLQEKIY | 386 | Q92753 | |
| QYKVVVPKIGNILDL | 491 | Q9Y4E8 | |
| LLVKNNEQVYIPKSL | 521 | Q9HBJ7 | |
| TEKLLQRIKEILPQY | 211 | Q8IYM2 | |
| ELYLKLQEQNIKPQF | 301 | Q9NVG8 | |
| LNALKTVINDPLYKE | 426 | O75310 | |
| QILAKIPSENNKLTY | 31 | P51809 | |
| LLQEKQKAQKTPYIV | 771 | O43290 | |
| LEINPKLQTQVKGYL | 201 | Q9H892 | |
| LLNALKSVINDPVYK | 426 | P54855 | |
| QLLYQLPNNKLLTTK | 211 | Q6ZVT0 | |
| YQLKSPRIQKLLQEL | 2761 | Q6ZQQ6 | |
| DNLQKVLPVGVLYKV | 116 | Q03393 | |
| LLNALKSVINDPIYK | 426 | O75795 | |
| LSNKVSVKLLNPNYI | 2666 | O75962 | |
| LETIPLKLSQLQYRQ | 271 | Q5THJ4 | |
| RPLNIIYNPQAIKKV | 631 | Q5THJ4 |